US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
bioXXmed AG (T5O) 銘柄情報

bioXXmed AG (T5O)

0.00

0.00

(0.00%)

終了 6月21日 5:00AM

bioXXmed AG (T5O) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

-

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

148 €

発行済株式数

271,865

配当利回り

PER

-0.25

1 株当たり利益 (EPS)

-3.28

歳入

20.49k

純利益

-890.91k

bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its ... bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. bioXXmed AG was founded in 2000 and is based in Heidelberg, Germany. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

bioxxmed.ag

本社

Heidelberg, Germany

設立

2026

bioXXmed AG is listed in the Healthcare sector of the Tradegate (DE) with ticker T5O. The last closing price for bioXXmed was -. Over the last year, bioXXmed shares have traded in a share price range of 0.00 € to 0.00 €.

bioXXmed currently has 271,865 shares in issue. bioXXmed has a price to earnings ratio (PE ratio) of -0.25.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

T5O - Frequently Asked Questions (FAQ)

What is the current bioXXmed AG share price?

The current share price of bioXXmed AG is 0.00 €

How many bioXXmed AG shares are in issue?

bioXXmed AG has 271,865 shares in issue

What is the 1 year trading range for bioXXmed AG share price?

bioXXmed AG has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of bioXXmed AG?

The price to earnings ratio of bioXXmed AG is -0.25

What is the cash to sales ratio of bioXXmed AG?

The cash to sales ratio of bioXXmed AG is 10.88

What is the registered address of bioXXmed AG?

The registered address for bioXXmed AG is Ziegelhäuser Landstraße 3, Heidelberg, 69120

What is the bioXXmed AG website address?

The website address for bioXXmed AG is bioxxmed.ag

Which industry sector does bioXXmed AG operate in?

bioXXmed AG operates in the Biotechnology & Life Sciences sector

Implanting

Implanting 3分前

Yes, the different timelines from past bubbles IMO can come sooner or later as they move forward. The stats show us that, but most of these bubbles come from a result of some sort of new technology or advent (like the railroads or early telegraph/telephone) that changed the world forever.

surrealistrader

surrealistrader 4分前

Nobody needs that level of stress. I’d much prefer being bored than terrorized by my holdings in retirement.

If Sidney sat on an economic mineral deposit, I think we should suppose their actions would have gone differently over these years. They would have begun working to prove their

MONTI KING

MONTI KING 11分前

I feel like it is very likely that ENZC might merge with VGLS/ bio molecular.

Henk van vleuten

Henk van vleuten 11分前

What about coming week, we ended good on friday. Are you Guys expecting a Russel run up or we have to wait for news?

beartrap12

beartrap12 20分前

Mani, approval will not be held up by construction of the C-suite. As you know, according to the last quarterly the company plans to lease a fully-operational c-suite and use those clean rooms. That means they can start sooner than if they wait to build out the Sawston C-suite.

From t

tradedays1224

tradedays1224 23分前

Only have year until his note conversion then he will do huge RS. That’s the only way he wants it to move… when he can benefit… that is why he switch to saying good things “take time”

sunspotter

sunspotter 27分前

"Excellent writing skill"

The poster used an AI Large Language Model to generate that post - such models can produce good prose, but are also prone to hallucinations.

Better to rely on common sense than ChatGPT fed with a leading and biased question.

In t

capgain

capgain 28分前

Happy Fathers Day all.

frrol

Welcome to reality. Keep your head out of the sand.

theorysuit

theorysuit 28分前

Speculation. Why would you need to be speculating? Oh yeah the company doesn't update you. Is it approved yet close to 3 years since submission....nope that is beyond ridiculous. Keep it simple stupid....KISS

flipper44

flipper44 30分前

BNOS Conference Theme “Local-Therapies for Brain Cancer” celebrates the exciting progress at the crossroads of neuro-oncology, biology, and technology, advances that are transforming treatment approaches and offering new hope for patients. — BNOS Congress July 1-3, 2026

http

exisnet

exisnet 30分前

$ERII has the potential be big with Iran becoming a 'normal' country

NASDAQ2020

NASDAQ2020 43分前

Elite's Unique IR ADF is 90% cheaper to produce compared to ADFs containing Naltrexone.

Patent Pending
NDA ?

Quote Nasrat:

”I am extremely excited about this formulation because it is also a platform that applies to all the IRs and its about 10

DJurg

What is the estimate for the #MW FCEL will ship this year? Anyone?

tkg

Credit again to DJknows for bringing this to our attention...this is a very intriguing company the more I look into it!

IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist
19 Jun 2026
4 min read

https://iqm.tech/pres

Bngo

Do you still think Elite is scam? Are you still just asking for just $0.12, or do you think Elite is worth much more than $0.12?

Elite made the list!

84% confidence

ROE: 32.9%

Debt/Equity: 0.02x

Net Marg

Lime Time

Lime Time 56分前

I will put all my paper boy money into this. Some new entity will run this like 2021 craze. Happy Father's Day

Bngo

Bngo 1時間前

Are you still just asking for just $1.50, or do you think Elite is worth much more than $1.50?
Elite made the list!

84% confidence

ROE: 32.9%

Debt/Equity: 0.02x

Net Margin: 24.4%

Rev G

PutzMueler

PutzMueler 1時間前

The more the merrier.

NioCorp’s Mgmt, is NioCorp’s Fatal Flaw

REE’s not in the plans until they had no choice.

Just my opinion.

100lbStriper

100lbStriper 1時間前

Netlist demands ban on Samsung HBM and DRAM in the US https://www.sammyfans.com/2026/06/20/netlist-demands-ban-on-samsung-hbm-and-dram-in-the-us/#google_vignette

100lbStriper

100lbStriper 1時間前

2 weeks old, nlst gets plugged at about 3:50 on the clip....... https://www.youtube.com/watch?v=bX8m2ibc94k

tkg

Amazon Braket launches new 54-qubit superconducting quantum processor from IQM
by Zia Mohammad, Charunethran Panchalam Govindarajan, Peter Komar, and Stefan Seegerer on 21 JUL 2025 in Amazon Braket, Quantum Technologies Permalink

Amazon Braket enables customers to design and

iNAV db x trackers MSCI ...

Lehman Br Tr 05/35flrmtn

Highland Copper

Heidelberger Druck Dem (PK)

LENZ Therapeutics

Kongsberg Automotive Asa (PK)

Domestic bond 0.675% 7de...

Access Protocol

iShares S&P Small Cap 60...

HSBC Bloomberg Global ES...

Invesco Large Cap Growth...

GLOBAL X AGTECH & FOOD I...

Corix Bioscience (EM)

Mortgage Advice Bureau (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。